DORALESE

This brand name is authorized in United Kingdom

Active ingredients

The drug DORALESE contains one active pharmaceutical ingredient (API):

1 Indoramin UNII DQ0Z3K8W92 - INDORAMIN HYDROCHLORIDE

Indoramin is an alpha adrenoceptor blocking agent. It acts selectively and competitively on post-synaptic alpha-1 receptors, causing a decrease in peripheral resistance. It also produces relaxation of hyperplastic muscle in the prostate. Read about Indoramin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DORALESE Film-coated tablets	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C02CA02	Indoramin	C Cardiovascular system → C02 Antihypertensives → C02C Antiadrenergic agents, peripherally acting → C02CA Alpha-adrenoreceptor antagonists
Discover more medicines within C02CA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 161598, 33550